Product Information

AMPHETAMINE ER 12.5 MG ODT is a generic product labeled by Neos Therapeutics Brands, LLC, priced at $15.3513 per EA under NDC 62542002030. Its NADAC has been published 49 times since Dec 17, 2025.

FDA first approved this application on Jan 27, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMPHETAMINE ER 12.5 MG ODT

Amphetamine Extended-Release
$15.3513per EA
DEA Schedule CII

Strength

12.5 mg/1

NDC

62542002030

Classification

Generic

Dosage Form

TABLET, ORALLY DISINTEGRATING

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

AMPHETAMINE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA204326

FDA Approved

1/27/2016

TE Code

AB

On Market Since

9/1/2025

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for AMPHETAMINE ER 12.5 MG ODT has been published 49 times since Dec 17, 2025, and over the history we have for it it has declined 7.2%. The table below summarizes its recorded NADAC range and movement.

Current price$15.3513 per EA
All-time high$16.5820 (Apr 15, 2026)
All-time low$15.3513 (Nov 18, 2026)
52-week high$16.5820
52-week low$15.3513
Median price$16.4277
Average price$16.3177
Largest weekly change-2.4% (Oct 21, 2026)
Weeks tracked49
Tracking sinceDec 17, 2025

Price History

1W

-1.5%

1M

-1.5%

3M

-5.5%

6M

-6.6%

1Y

N/A

3Y

N/A

5Y

N/A

All

-7.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Amphetamine Extended-Release market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of AMPHETAMINE ER 12.5 MG ODT?

The current National Average Drug Acquisition Cost (NADAC) for AMPHETAMINE ER 12.5 MG ODT, manufactured by Neos Therapeutics Brands, LLC, is $15.3513 per EA (NDC 62542002030), effective Nov 18, 2026.

How has the price of AMPHETAMINE ER 12.5 MG ODT changed over time?

Over the history we have for it, the NADAC for AMPHETAMINE ER 12.5 MG ODT has declined 7.2%. It has been tracked across 49 weekly CMS publications since Dec 17, 2025.

What are the highest and lowest recorded NADAC prices for AMPHETAMINE ER 12.5 MG ODT?

Since Dec 17, 2025, the NADAC for AMPHETAMINE ER 12.5 MG ODT has ranged from a low of $15.3513 (Nov 18, 2026) to a high of $16.5820 (Apr 15, 2026), with a median of $16.4277 per EA.

Are there cheaper alternatives to AMPHETAMINE ER 12.5 MG ODT?

No other NADAC-published product currently shares the active ingredient and strength of AMPHETAMINE ER 12.5 MG ODT in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures AMPHETAMINE ER 12.5 MG ODT?

AMPHETAMINE ER 12.5 MG ODT (NDC 62542002030) is labeled by Neos Therapeutics Brands, LLC, and CMS classifies it as a generic product.